WeightWatchers is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business. MedTwitter weightloss
- WW International Inc, known as WeightWatchers, said on Monday it is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business.
Launched in 2021, Sequence now serves about 24,000 members across the U.S., as of February 2023, and clocks about $25 million in annual revenue on a run-rate basis.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WeightWatchers to buy Sequence telehealth, enter obesity drug prescription businessWW International Inc, known as WeightWatchers, said on Monday it is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business. WeighWatchers said it expects its $132 million acquisition in cash and stock will complement its nutrition and behavior-change program for weight loss at a time when obesity drugs are seen as one of the biggest markets for drugmakers.
Read more »
WeightWatchers buys telehealth platform Sequence, facilitating access to Ozempic and WegovyThe diet company is hoping to offer members the ability to meet with clinicians who can prescribe obesity and diabetes medications.
Read more »
WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Read more »
WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Read more »
WeightWatchers is acquiring Sequence for $106 millionWeightWatchers is buying a company that lets you pay $99 a month to see a doctor on video and get a prescription to popular weight-loss drug Ozempic
Read more »
WeightWatchers Is Getting In on the Ozempic BoomThe company acquired telehealth provider Sequence, which prescribes weight-loss drugs, for $106 million.
Read more »